These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7234454)

  • 1. Influence of estrogens on tuberoinfundibular and striatal dopaminergic systems in the rat.
    Labrie F; Ferland L; Veilleux R; Euvrard C; Boissier J
    Acta Psychiatr Belg; 1980; 80(5):658-73. PubMed ID: 7234454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of estrogens on tuberoinfundibular and striatal dopaminergic systems in the rat.
    Labrie F; Ferland L; Veilleux R; Euvrard C; Boissier J
    Acta Psychiatr Belg; 1979; 79(6):623-37. PubMed ID: 554444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specific role of sex steroids on the pituitary level. Sex steroids and anterior pituitary secretion].
    Labrie F; Lagace L; Drouin J; De Lean A; Beaulieu M; Ferland L; Raymond V
    Bull Schweiz Akad Med Wiss; 1978 Mar; 34(1-3):171-90. PubMed ID: 208692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between hypothalamic and peripheral hormones in the control of prolactin secretion.
    Ferland L; Labrie F; Kelly PA; Raymond V
    Fed Proc; 1980 Sep; 39(11):2917-22. PubMed ID: 7409210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidopaminergic effect of estrogens at the striatal level.
    Euvrard C; Oberlander C; Boissier JR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):179-85. PubMed ID: 7391967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidopaminergic activity of estrogens on prolactin release at the pituitary level in vivo.
    Ferland L; Labrie F; Euvrard C; Raynaud JP
    Mol Cell Endocrinol; 1979 Jun; 14(3):199-204. PubMed ID: 467781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modification of the nigro-striatal system by estrogens and prolactin. Clinical and experimental data].
    Tigano G; Marano P; Patti F; Cammmarata C; De Simone D; Rampello L; Nicoletti F
    Boll Soc Ital Biol Sper; 1982 Aug; 58(16):1054-60. PubMed ID: 7138674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrabenazine has properties of a dopamine receptor antagonist.
    Login IS; Cronin MJ; MacLeod RM
    Ann Neurol; 1982 Sep; 12(3):257-62. PubMed ID: 7137960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal changes in prolactin and growth hormone secretion in vitro after in vivo estrogen treatment.
    Horváth JE; Schally AV
    Acta Biol Hung; 1994; 45(2-4):249-62. PubMed ID: 7725821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prolactin on central dopaminergic neurons.
    Moore KE; Demarest KT
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):645-50. PubMed ID: 6891823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tachykinins and the control of prolactin secretion.
    Debeljuk L; Lasaga M
    Peptides; 2006 Nov; 27(11):3007-19. PubMed ID: 16930771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
    Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR
    J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogens exert a rapid apoptotic action in anterior pituitary cells.
    Zárate S; Jaita G; Zaldivar V; Radl DB; Eijo G; Ferraris J; Pisera D; Seilicovich A
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E664-71. PubMed ID: 19158323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of anterior pituitary dopamine receptors by estradiol 17-beta: dose-response relationship.
    Ali SF; Peck EJ
    J Neurosci Res; 1985; 13(4):497-507. PubMed ID: 4009741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D5 receptor localization on cholinergic neurons of the rat forebrain and diencephalon: a potential neuroanatomical substrate involved in mediating dopaminergic influences on acetylcholine release.
    Berlanga ML; Simpson TK; Alcantara AA
    J Comp Neurol; 2005 Nov; 492(1):34-49. PubMed ID: 16175554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of prolactin on dopaminergic neuronal systems in the hypothalamus.
    Moore KE; Demarest KT; Johnston CA
    Fed Proc; 1980 Sep; 39(11):2912-6. PubMed ID: 7409209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
    Christian HC; Chapman LP; Morris JF
    J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic modulation of nNOS expression in the pituitary gland of male rat.
    Carretero J; Weruaga E; Hernández E; Burks D; Riesco JM; Rubio M; Briñón JG; Aijón J; Vázquez R; Alonso JR
    Anat Embryol (Berl); 2003 Dec; 207(4-5):381-8. PubMed ID: 14618399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic mechanisms involved in prolactin release after mifepristone and naloxone treatment during late pregnancy in the rat.
    Soaje M; Valdez S; Bregonzio C; Penissi A; Deis RP
    Neuroendocrinology; 2006; 84(1):58-67. PubMed ID: 17090971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydroepiandrosterone (DHEA) modulates GHRH, somatostatin and angiotensin II action at the pituitary level.
    Suárez C; Vela J; García-Tornadú I; Becu-Villalobos D
    J Endocrinol; 2005 Apr; 185(1):165-72. PubMed ID: 15817837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.